載入...
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
Cancer immunotherapy has evolved dramatically with improved understanding of immune microenvironment and immunosurveillance. The immunogenicity of breast cancer is rather heterogeneous. Specific subtypes of breast cancer such as estrogen receptor (ER)-negative, human EGF receptor 2 (HER2)-positive,...
Na minha lista:
| 發表在: | Breast Cancer (Dove Med Press) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6340364/ https://ncbi.nlm.nih.gov/pubmed/30697064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S175360 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|